메뉴 건너뛰기




Volumn 78, Issue 3, 2013, Pages 285-290

Fibroblast Growth Factor 23, Hepatocyte Growth Factor, Interleukin-6, High-Sensitivity C-Reactive Protein and Soluble Urokinase Plasminogen Activator Receptor. Inflammation Markers in Chronic Haemodialysis Patients?

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBROBLAST GROWTH FACTOR 23; INTERLEUKIN 6; SCATTER FACTOR; UROKINASE RECEPTOR;

EID: 84883009284     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12082     Document Type: Article
Times cited : (11)

References (27)
  • 1
    • 0035568843 scopus 로고    scopus 로고
    • Malnutrition, inflammation and atherosclerosis in peritoneal dialysis patients
    • Stenvinkel P, Chung SH, Heimburger O, Lindholm B. Malnutrition, inflammation and atherosclerosis in peritoneal dialysis patients. Perit Dial Int 2001;21(Suppl. 3):157-62.
    • (2001) Perit Dial Int , vol.21 , Issue.SUPPL , pp. 157-162
    • Stenvinkel, P.1    Chung, S.H.2    Heimburger, O.3    Lindholm, B.4
  • 2
    • 0035999931 scopus 로고    scopus 로고
    • Inflammation and cardiovascular risk in dialysis patients
    • Wanner C, Zimmerman J, Shwedler S, Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int 2002;61:99-102.
    • (2002) Kidney Int , vol.61 , pp. 99-102
    • Wanner, C.1    Zimmerman, J.2    Shwedler, S.3    Metzger, T.4
  • 3
    • 0038119501 scopus 로고    scopus 로고
    • Association of interleukin-6-174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients
    • Losito A, Kalidas K, Santoni S, Jeffery S. Association of interleukin-6-174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients. Kidney Int 2003;64:616-22.
    • (2003) Kidney Int , vol.64 , pp. 616-622
    • Losito, A.1    Kalidas, K.2    Santoni, S.3    Jeffery, S.4
  • 4
    • 84872287337 scopus 로고    scopus 로고
    • Association of cardiac valvular calcifications and c-reactive protein with cardiovascular mortality in incident hemodialysis patients: A Japanese cohort study
    • Takahashi H, Ishii H, Aoyama T et al. Association of cardiac valvular calcifications and c-reactive protein with cardiovascular mortality in incident hemodialysis patients: A Japanese cohort study. Am J Kidney Dis 2013;61:254-61.
    • (2013) Am J Kidney Dis , vol.61 , pp. 254-261
    • Takahashi, H.1    Ishii, H.2    Aoyama, T.3
  • 5
    • 0033984744 scopus 로고    scopus 로고
    • Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
    • Yudkin JS, Kumari M, Humphries SE, Mohammed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209-14.
    • (2000) Atherosclerosis , vol.148 , pp. 209-214
    • Yudkin, J.S.1    Kumari, M.2    Humphries, S.E.3    Mohammed-Ali, V.4
  • 7
    • 84866762818 scopus 로고    scopus 로고
    • An Antithrombin III product containing biologically active hepatocyte growth factor may be beneficial in deep ulcer infections
    • Lönn J, Almroth G, Brudin L, Nayeri F. An Antithrombin III product containing biologically active hepatocyte growth factor may be beneficial in deep ulcer infections. Cytokine 2012;60:478-86.
    • (2012) Cytokine , vol.60 , pp. 478-486
    • Lönn, J.1    Almroth, G.2    Brudin, L.3    Nayeri, F.4
  • 8
    • 84855719213 scopus 로고    scopus 로고
    • Hepatocyte growth factor in patients with coronary artery disease and its relation to periodontal condition
    • Lönn J, Starkhammar Johansson C, Kälvegren H et al. Hepatocyte growth factor in patients with coronary artery disease and its relation to periodontal condition. Results Immunol 2012;2:7-12.
    • (2012) Results Immunol , vol.2 , pp. 7-12
    • Lönn, J.1    Starkhammar Johansson, C.2    Kälvegren, H.3
  • 9
    • 84882944149 scopus 로고    scopus 로고
    • High concentrations of hepatocyte growth factor but low biological activity in patients with periodontitis
    • Epub a head of print]
    • Lönn J, Starkhammar JC, Sridhar S, Bengtsson T, Nayeri F, Ravald N. High concentrations of hepatocyte growth factor but low biological activity in patients with periodontitis. J Periodontol 2013. [Epub a head of print].
    • (2013) J Periodontol
    • Lönn, J.1    Starkhammar, J.C.2    Sridhar, S.3    Bengtsson, T.4    Nayeri, F.5    Ravald, N.6
  • 10
    • 84888837718 scopus 로고    scopus 로고
    • High concentration but low biological activity of hepatocyte growth factor in patients with chronic renal failure
    • Lönn J, Shahzad F, Uhlin F, Bengtsson T, Almroth G, Nayeri F. High concentration but low biological activity of hepatocyte growth factor in patients with chronic renal failure. Adv Biosci Biotechnol 2012;3:516-23.
    • (2012) Adv Biosci Biotechnol , vol.3 , pp. 516-523
    • Lönn, J.1    Shahzad, F.2    Uhlin, F.3    Bengtsson, T.4    Almroth, G.5    Nayeri, F.6
  • 11
    • 77951682465 scopus 로고    scopus 로고
    • The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe?
    • Larsson TE. The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe? Nephrol Dial Transplant 2010;25:1376-81.
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 1376-1381
    • Larsson, T.E.1
  • 12
    • 80555148939 scopus 로고    scopus 로고
    • FGF23 induces left ventricular hypertrophy
    • Faul C, Amarai AP, Oskouei B et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011;121:4393-408.
    • (2011) J Clin Invest , vol.121 , pp. 4393-4408
    • Faul, C.1    Amarai, A.P.2    Oskouei, B.3
  • 14
    • 84872193128 scopus 로고    scopus 로고
    • Association of Circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal function
    • Wang M, You L, Li H, Zhang Z, Hao C, Chen J. Association of Circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal function. Clin J Am Soc Nephrol 2013;8:116-25.
    • (2013) Clin J Am Soc Nephrol , vol.8 , pp. 116-125
    • Wang, M.1    You, L.2    Li, H.3    Zhang, Z.4    Hao, C.5    Chen, J.6
  • 16
    • 84867520418 scopus 로고    scopus 로고
    • Vascular endothelial growth factor and uPAR/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis?
    • Epub 2012 May 8
    • Pawlak K, Ulazka B, Mysliwiec M, Pawlak D. Vascular endothelial growth factor and uPAR/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis? Transl Res 2012;160:346-54. Epub 2012 May 8.
    • (2012) Transl Res , vol.160 , pp. 346-354
    • Pawlak, K.1    Ulazka, B.2    Mysliwiec, M.3    Pawlak, D.4
  • 17
    • 84870296762 scopus 로고    scopus 로고
    • Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention
    • Lyngbaek S, Marott JL, Möller DV et al. Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention. Am J Cardiol 2012;110:156-63.
    • (2012) Am J Cardiol , vol.110 , pp. 156-163
    • Lyngbaek, S.1    Marott, J.L.2    Möller, D.V.3
  • 18
    • 77954381132 scopus 로고    scopus 로고
    • Proinflammatory cytokines, hepatocyte growth factors and adipokines in peritoneal dialysis patients
    • Lee C-T, Ng H-Y, Hsu C-Y et al. Proinflammatory cytokines, hepatocyte growth factors and adipokines in peritoneal dialysis patients. Artif Organs 2010;34:222-9.
    • (2010) Artif Organs , vol.34 , pp. 222-229
    • Lee, C.-T.1    Ng, H.-Y.2    Hsu, C.-Y.3
  • 19
    • 84860805316 scopus 로고    scopus 로고
    • Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients
    • Jean G, Bresson E, Lorriaux C et al. Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients. Nephron Clin pract 2012;120:132-8.
    • (2012) Nephron Clin pract , vol.120 , pp. 132-138
    • Jean, G.1    Bresson, E.2    Lorriaux, C.3
  • 20
    • 84883035794 scopus 로고    scopus 로고
    • Serum FGF-23 is linked with increased inflammatory cytokines in CKD stage 3-5. Is this the explanation for its adverse CV effects? Abstract Am Soc Nephrol, and European Renal Association (ERA EDTA); 2012, FP246
    • Chitalia N, Afzali B, Edozie F et al. Serum FGF-23 is linked with increased inflammatory cytokines in CKD stage 3-5. Is this the explanation for its adverse CV effects? Abstract Am Soc Nephrol 2012, and European Renal Association (ERA EDTA); 2012, FP246.
    • (2012)
    • Chitalia, N.1    Afzali, B.2    Edozie, F.3
  • 21
    • 77749334660 scopus 로고    scopus 로고
    • Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy
    • Oliveira RB, Cancela ALE, Graciolli FG et al. Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy. Clin J Am Soc Nephrol 2010;5:286-91.
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 286-291
    • Oliveira, R.B.1    Cancela, A.L.E.2    Graciolli, F.G.3
  • 22
    • 84871675923 scopus 로고    scopus 로고
    • The effect of Cinacalcet on cardiovascular disease in patients undergoing dialysis. The Evolve trial investigators
    • Dec 27
    • Chertow GM, Block GA, Correa-Rotter R et al. The effect of Cinacalcet on cardiovascular disease in patients undergoing dialysis. The Evolve trial investigators. N Engl J Med 2012;367:2482-94 (Dec 27).
    • (2012) N Engl J Med , vol.367 , pp. 2482-2494
    • Chertow, G.M.1    Block, G.A.2    Correa-Rotter, R.3
  • 23
    • 79952758440 scopus 로고    scopus 로고
    • Achievement of recommended treatment targets for bone and mineral metabolism in haemodialysis patients using paricalcitol: an observational study
    • Fernstrom A, Giaever J, Granroth B et al. Achievement of recommended treatment targets for bone and mineral metabolism in haemodialysis patients using paricalcitol: an observational study. Scand J Urol Nephrol 2011;45:196-205.
    • (2011) Scand J Urol Nephrol , vol.45 , pp. 196-205
    • Fernstrom, A.1    Giaever, J.2    Granroth, B.3
  • 24
    • 84876796232 scopus 로고    scopus 로고
    • Determinants of FGF23 and PTH Variability in Dialysis Patients
    • Jia T, Qureshi AR, Gross T et al. Determinants of FGF23 and PTH Variability in Dialysis Patients. Am J Nephrol 2013;37:462-71.
    • (2013) Am J Nephrol , vol.37 , pp. 462-471
    • Jia, T.1    Qureshi, A.R.2    Gross, T.3
  • 25
    • 84877599062 scopus 로고    scopus 로고
    • FGF-23 and the progression of coronary artery calcification in patients new to dialysis
    • Khan AM, Chirinos JA, Litt H, Yang W, Rosas SE. FGF-23 and the progression of coronary artery calcification in patients new to dialysis. Clin J Am Soc Nephrol 2012;7:2017-22.
    • (2012) Clin J Am Soc Nephrol , vol.7 , pp. 2017-2022
    • Khan, A.M.1    Chirinos, J.A.2    Litt, H.3    Yang, W.4    Rosas, S.E.5
  • 26
    • 49249104701 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
    • Gutiérrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008;359:584-92.
    • (2008) N Engl J Med , vol.359 , pp. 584-592
    • Gutiérrez, O.M.1    Mannstadt, M.2    Isakova, T.3
  • 27
    • 84870546490 scopus 로고    scopus 로고
    • Circulating suPAR in two cohorts of primary FSGS
    • Trachtman H, Li J, Wei C et al. Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 2012;23:2051-9.
    • (2012) J Am Soc Nephrol , vol.23 , pp. 2051-2059
    • Trachtman, H.1    Li, J.2    Wei, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.